Conclusion: Drug-Related Deaths, Missed Opportunities and the Appliance of Science The start of the N-ALIVE trial is a highly significant scientific step in the development of an evidence-based harm reduction initiative to stem the hemorrhage of heroin overdose deaths that has been identified as occurring in the period immediately post-prison release.
← all excerpts
Take-home emergency naloxone to prevent heroin overdose deaths after prison release: rationale and practicalities for the N-ALIVE randomized trial.
1
—
—